Read More Analyst Ratings Initiation News Price Target Mizuho Initiates Coverage On Oracle with Buy Rating, Announces Price Target of $116 By Benzinga Newsdesk January 11, 5:56 AM Mizuho analyst Siti Panigrahi initiates coverage on Oracle (NYSE:ORCL) with a Buy rating and announces Price Target of $116. ORCL
Read More Analyst Ratings News Price Target Wells Fargo Maintains Overweight on KLA, Raises Price Target to $420 By Benzinga Newsdesk December 7, 9:30 AM Wells Fargo analyst Joseph Quatrochi maintains KLA (NASDAQ:KLAC) with a Overweight and raises the price target from $360 to $420. KLAC
Read More Commodities Earnings Equities Eurozone Intraday Update Markets News Trading Ideas Crude Oil Rises Sharply; Elbit Systems Shares Fall After Q1 Results By Avi Kapoor May 28, 2:34 PM U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 250… APDN
Read More Biotech General Guidance News Compass Therapeutics Provides Corporate Update By Benzinga Newsdesk January 5, 9:11 AM We continue to open clinical sites and enroll patients in COMPANION-002, the Phase 2/3 randomized study of CTX-009 (DLL4 x VEGF-A bispecific antibody) in patients with advanced biliary tract cancer (BTC). Consistent with CMPX